Short answer

Designers of cardiovascular monitoring or therapeutic devices should consider the dynamic vasomotor capabilities of early-stage collateral vessels, rather than assuming they are static or non-functional.

Field: Human Factors
Source: Academic Publication (2011)
Method: Experimental study
Evidence: Strong effect

Newly developed coronary collateral vessels, even shortly after occlusion, possess substantial vasomotor capabilities, indicating their potential to actively regulate blood flow. This human factors research insight is drawn from a 2011 study published in Academic Publication. Using Experimental study, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers of cardiovascular monitoring or therapeutic devices should consider the dynamic vasomotor capabilities of early-stage collateral vessels, rather than assuming they are static or non-functional.

Study

Human FactorsHigh ImpactStrong effect

Early-stage coronary collateral vessels exhibit significant vasomotor activity

Newly developed coronary collateral vessels, even shortly after occlusion, possess substantial vasomotor capabilities, indicating their potential to actively regulate blood flow.

Academic Publication · 2011

Key Findings

01Newly developed coronary collateral vessels demonstrate substantial vasomotor capability.
02Both nitric oxide and cyclooxygenase-dependent endothelial mechanisms are intact in these early-stage vessels.
03Nitroglycerin increased collateral blood flow, indicating vasodilation.
04Indomethacin (cyclooxygenase blockade) decreased collateral blood flow.
05Acetylcholine induced vasodilation, suggesting intact endothelium-mediated responses.

Application

Design takeaway

How to apply

When designing a device to assist blood flow in patients with coronary artery disease, consider how the device could interact with or enhance the natural vasodilation and vasoconstriction capabilities of newly formed collateral vessels.

Project actions

01Consider how your design could interact with or influence the body's natural physiological responses.
02Research the specific biological mechanisms relevant to your design context to understand potential interactions.

Method & Evidence

AimTo determine if newly developed coronary collateral vessels possess active vasomotor activity and if their endothelial function is impaired.

MethodExperimental study

ProcedureResearchers measured retrograde blood flow in dogs approximately 2 weeks after coronary artery occlusion. They administered various agonists and blockers (nitroglycerin, indomethacin, acetylcholine, NG-nitro-L-arginine) into the coronary artery to assess collateral blood flow and endothelial responses.

ContextCardiovascular research, specifically the development and function of coronary collateral vessels.

Variables

IV["Administration of agonists/blockers (nitroglycerin, indomethacin, acetylcholine, NG-nitro-L-arginine)"]

DV["Retrograde blood flow (index of collateral blood flow)"]

CV["Time after occlusion (approx. 2 weeks)","Species (dogs)","Method of occlusion (embolic)"]

Strengths & Limitations

Strengths

+Directly investigates the functional capacity of newly developed collateral vessels.
+Utilizes pharmacological agents to probe specific endothelial pathways.

Limitations

The study uses animal models, so direct application to human physiology requires caution. The specific time point studied (2 weeks post-occlusion) might not represent all stages of collateral development.

Reliability & validity

The use of controlled experimental conditions and specific pharmacological agents enhances the internal validity. However, the generalizability (external validity) to human physiology is limited due to the animal model.

Think critically

How might the observed vasomotor activity of collateral vessels be influenced by factors such as age, pre-existing conditions, or different types of occlusive events?

Design Principles

"Design for dynamic physiological response: Account for the active regulatory mechanisms within biological systems when developing medical technologies."

This finding is crucial for designing medical devices and interventions aimed at improving blood flow in compromised cardiac regions. Understanding the inherent vasomotor capacity of these vessels allows for the development of more targeted and effective therapeutic strategies.

What This Means for Your Design

Even when new blood vessels form after a blockage, they can still actively open and close to control blood flow, and they respond well to signals from the body's own chemical messengers.

How to use in your project

1.Reference this study when discussing the physiological context of a medical device design, particularly if it aims to improve blood flow or cardiac function.
2.Use the findings to justify design choices that aim to work with, rather than against, the body's natural regulatory processes.

Add to My Project

Quick Cite

Paragraph starter

This research highlights that early-stage coronary collateral vessels possess significant vasomotor activity and intact endothelial function, responding to both nitric oxide and cyclooxygenase-dependent mechanisms. This understanding is critical for designing medical devices that aim to modulate blood flow, as it suggests that interventions can leverage these inherent regulatory capabilities rather than solely relying on passive flow augmentation.

Source

Academic Publication

Technologies for Wearable and Portable Physiological Measurement Devices

journal · 2011

View source

Questions About This Research

What does the research say about early-stage coronary collateral vessels exhibit significant vasomotor activity?: Designers of cardiovascular monitoring or therapeutic devices should consider the dynamic vasomotor capabilities of early-stage collateral vessels, rather than assuming they are static or non-functional. Evidence: Academic Publication (2011).
Why does "Early-stage coronary collateral vessels exhibit significant vasomotor activity" matter for design?: This finding is crucial for designing medical devices and interventions aimed at improving blood flow in compromised cardiac regions. Understanding the inherent vasomotor capacity of these vessels allows for the development of more targeted and effective therapeutic strategies.
How can designers apply this research?: Designers of cardiovascular monitoring or therapeutic devices should consider the dynamic vasomotor capabilities of early-stage collateral vessels, rather than assuming they are static or non-functional.
What were the main findings?: Newly developed coronary collateral vessels demonstrate substantial vasomotor capability.. Both nitric oxide and cyclooxygenase-dependent endothelial mechanisms are intact in these early-stage vessels.. Nitroglycerin increased collateral blood flow, indicating vasodilation.. Indomethacin (cyclooxygenase blockade) decreased collateral blood flow.
What research method was used?: Experimental study.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2011 journal from Academic Publication.
What should I do differently in my next project?: When designing a device to assist blood flow in patients with coronary artery disease, consider how the device could interact with or enhance the natural vasodilation and vasoconstriction capabilities of newly formed collateral vessels.
What are the limitations?: The study was conducted in dogs, and findings may not directly translate to humans. The specific timing of 'early' development (2 weeks) might influence the degree of vasomotor activity observed.